(InvestigateTV) — The Cleveland Clinic for Brain Health in Las Vegas is conducting a clinical trial that’s taking a deeper look into Lecanemab, a drug the neurologist we spoke to says could prevent or delay the symptoms of Alzheimer’s.
Reporter Heather Graf shows us the research now underway, and how it could one day maybe help you or someone you know. Watch the full story in the video at the top of this story.
Lecanemab received accelerated FDA approval in January 2023 and traditional approval in July, for use in patients with early signs of Alzheimer’s and dementia.
Dr. Charles Bernick is heading up a study testing the drug in people who are not experiencing symptoms.
The clinical trial started in 2023 and will run for four years. The participants are over the age of 55, have a family history of Alzheimer’s disease, and have noticed some memory changes in themselves.
Copyright 2023 Gray Media Group, Inc. All rights reserved.